2018 Education Patient-Centered Provider 
Physician's Weekly
JUNE 19, 2025
Mental health and SUD bias impact the quality of ED care that patients with these conditions receive for physical health concerns, according to research. What the Patients Said According to the study, three key themes emerged: Negative encounters dominated. Isbell, PhD , of the University of Massachusetts Amherst, and colleagues.
The Medical Futurist
JUNE 21, 2025
The California-based firm, Second Sight , the German company, Retina Implant AG, and the French venture, Pixium Vision were the forerunners of the field, developing implantable visual prosthetics to restore vision to patients who are blind as a result of the rare condition of retinitis pigmentosa.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
OCTOBER 18, 2022
Milburn Smith Child Health Research, Outreach, and Advocacy Center at the Ann & Robert H. All healthcare professionals will have patients who are directly or indirectly impacted by the carceral system. People who are incarcerated are dehumanized and feel they are treated as inmates, rather than as patients.
The Clinical Problem Solvers
DECEMBER 16, 2020
Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality. Where can you give an extra inch to those for whom you are caring?
PEMBlog
APRIL 22, 2025
While we pride ourselves on providing high-quality care for all children, we must acknowledge that the noisy, fast-paced, and unpredictable environment of the ED can be especially distressing for autistic patients. What you can do: Incorporate ASD care into simulation scenarios, staff onboarding, and continuing education.
FDA Law Blog
JULY 7, 2021
In March 2020, FDA issued a final rule that banned the use of Graduated Electronic Decelerators (GEDs) to treat patients with severe self-injurious and aggressive behaviors (SIB/AB), but did not restrict the use of these same devices for other purposes, like smoking cessation. Circuit Court of Appeals to overturn the ban.
PEMBlog
APRIL 20, 2023
Cristina Tarango, director of the Hemophilia Treatment Center at Cincinnati Children’s and Lisa Littner, Project Manager at Cincinnati Children’s who helped me research and write this post. Emicizumab (Hemlibra) was approved in 2018 for routine bleeding prophylaxis in hemophilia A with or without inhibitors. Factor first!
Expert insights. Personalized for you.
52 
Let's personalize your content